SMS Lifesciences India has reported results for the second quarter ended September 30, 2020.
The company has reported a fall of 10.57% in its net profit at Rs 3.13 crore for the quarter under review as compared to net profit of Rs 3.50 crore for the same quarter in the previous year. Total income of the company decreased by 16.07% at Rs 60.73 crore for Q2FY21 as compared Rs 72.36 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 10.05% in its net profit at Rs 3.31 crore for the quarter under review as compared to net profit at Rs 3.68 crore for the same quarter in the previous year. Total income of the company decreased by 19.62% at Rs 62.04 crore for Q2FY21 as compared Rs 77.18 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1462.50 |
Dr. Reddys Lab | 5784.50 |
Cipla | 1451.25 |
Zydus Lifesciences | 1001.15 |
Lupin | 1587.90 |
View more.. |